Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 249-254

Spandidos Publications

Access to resources Recommend Favorite

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

By Nakanishi Ryota   Harada Jun   Tuul Munkhbold   Zhao Yan   Ando Koji   Saeki Hiroshi   Oki Eiji   Ohga Takefumi   Kitao Hiroyuki   Kakeji Yoshihiro   Maehara Yoshihiko  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1042-1048

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of KRAS mutations in patients with colorectal cancer

By                  

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1579-1584

Spandidos Publications

Access to resources Recommend Favorite

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy

By                          

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1419-1426

Spandidos Publications

Access to resources Recommend Favorite